美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

HANGZHOU TIGERMED CONSULTING CO LTD.

4.45

0.0000

成交量：- -

成交额：- -

市值：38.33亿

市盈率：83.06

高：4.45

开：4.45

低：4.45

收：4.45

52周最高：4.45

52周最低：4.45

股本：8.61亿

流通股本：6.22亿

量比：- -

换手率：- -

股息：0.02

股息率：0.42%

每股收益(TTM):0.0536

每股收益(LYR):0.0643

净资产收益率：4.23%

总资产收益率：1.33%

市净率：1.23

市盈率(LYR):69.19

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计小幅增长，机构观点以谨慎偏多为主

财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计降2.47%，机构观点偏谨慎

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/HNGZY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HNGZY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HNGZY\",,,,,undefined,":{"symbol":"HNGZY","market":"US","secType":"STK","nameCN":"HANGZHOU TIGERMED CONSULTING CO LTD.","latestPrice":4.45,"timestamp":1787688000000,"preClose":4.45,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":622157332,"shares":861293370,"eps":0.053574,"marketStatus":"未开盘","change":0,"latestTime":"08-25 16:00:00 EDT 延时","open":4.45,"high":4.45,"low":4.45,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.053574,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":4.45,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HNGZY\",,,,,undefined,":{"symbol":"HNGZY","floatShares":622157332,"roa":"1.33%","roe":"4.23%","lyrEps":0.064314,"shares":861293370,"dividePrice":0.018747,"high":4.45,"amplitude":0,"preClose":4.45,"low":4.45,"week52Low":4.45,"pbRate":"1.23","psRate":"3.64","week52High":4.45,"institutionHeld":0,"latestPrice":4.45,"eps":0.053574,"divideRate":0.004213,"volume":0,"delay":15,"ttmEps":0.053574,"open":4.45,"prevYearClose":4,"prevWeekClose":4.45,"prevMonthClose":4.45,"prevQuarterClose":4.45,"fiveDayClose":4.45,"twentyDayClose":4.45,"sixtyDayClose":4,"earningDate":1787760000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HNGZY\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"HNGZY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787860800000,"name":null,"time":"盘后","dateTimestamp":1787803200000,"actualEps":null},{"date":"2026-06-22","symbol":"HNGZY","amount":0.01846,"announcedDate":"2026-06-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"HANGZHOU TIGERMED CONSULTING CO LTD.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-08-14"},{"market":"US","date":"2026-04-27","symbol":"HNGZY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1777262400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2026-03-30","symbol":"HNGZY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"","actualEps":null},{"date":"2025-06-13","symbol":"HNGZY","amount":0.041365,"announcedDate":"2025-06-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"HANGZHOU TIGERMED CONSULTING CO LTD.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HNGZY\",market:\"US\",,,undefined,":[{"executeDate":"2023-05-25","recordDate":"2023-05-26","paymentDate":null,"value":0.055696,"currency":"USD"},{"executeDate":"2024-06-11","recordDate":"2024-06-11","paymentDate":"2024-08-14","value":0.07984,"currency":"USD"},{"executeDate":"2025-06-13","recordDate":"2025-06-13","paymentDate":"2025-08-14","value":0.041365,"currency":"USD"},{"executeDate":"2026-06-22","recordDate":"2026-06-22","paymentDate":"2026-08-14","value":0.01846,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HNGZY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2353,"buy":0.5294,"hold":0.1176,"sell":0.1176,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5294,"analysts":17,"updateTime":1776312000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HNGZY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199581716","title":"财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计小幅增长，机构观点以谨慎偏多为主","url":"https://stock-news.laohu8.com/highlight/detail?id=1199581716","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1199581716?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 10:59","pubTimestamp":1787194776,"startTime":"0","endTime":"0","summary":"公司将于2026年08月27日发布财报，市场关注本季度营收和利润弹性以及费用投入节奏。公司上季度管理口径未披露对本季度的具体毛利率或净利率区间预测。上季度公司实现营收18.01亿元，同比增长15.69%；毛利率为26.64%；归属于母公司股东的净利润为4,904.31万元，净利率为2.72%；调整后每股收益为0.06元，同比下降68.42%。近期多家机构就本季度发表观点，倾向于谨慎偏多。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计小幅增长，机构观点以谨慎偏多为主","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HNGZY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173884529","title":"财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计降2.47%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1173884529","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173884529?lang=zh_cn&edition=fundamental","pubTime":"2026-04-20 09:34","pubTimestamp":1776648866,"startTime":"0","endTime":"0","summary":"HANGZHOU TIGERMED CONSULTING CO LTD.将于2026年04月27日披露最新季度业绩，市场关注营收、毛利率、净利率与每股收益的修复节奏及成本结构优化进展。市场一致预期本季度营收约19.37亿，同比-2.47%；每股收益约0.17元，同比-68.33%；息税前利润约1.63亿，同比-62.05%，公司未给出明确的毛利率、净利率或净利润指引。从体量看，Clinical trial related services and laboratory services为现有业务中规模最大的一项，上季度收入约34.47亿，受整体营收同比增长18.13%的带动，该板块对现金回流与毛利率修复的贡献将成为本季度观察重点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜HANGZHOU TIGERMED CONSULTING CO LTD.本季度营收预计降2.47%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HNGZY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HNGZY\",params:#limit:6,delay:false,,,undefined,":[]}}